John L. Marshall

26.6k total citations · 6 hit papers
431 papers, 16.4k citations indexed

About

John L. Marshall is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, John L. Marshall has authored 431 papers receiving a total of 16.4k indexed citations (citations by other indexed papers that have themselves been cited), including 257 papers in Oncology, 93 papers in Pulmonary and Respiratory Medicine and 86 papers in Molecular Biology. Recurrent topics in John L. Marshall's work include Colorectal Cancer Treatments and Studies (134 papers), Cancer Genomics and Diagnostics (64 papers) and Cancer Treatment and Pharmacology (61 papers). John L. Marshall is often cited by papers focused on Colorectal Cancer Treatments and Studies (134 papers), Cancer Genomics and Diagnostics (64 papers) and Cancer Treatment and Pharmacology (61 papers). John L. Marshall collaborates with scholars based in United States, Austria and United Kingdom. John L. Marshall's co-authors include F G Girgis, Joseph Fetto, Russell F. Warren, Sten‐Erik Olsson, Edith P. Mitchell, Thomas L. Wickiewicz, Benjamin A. Weinberg, Jimmy J. Hwang, Michael J. Pishvaian and Bruce Reider and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

John L. Marshall

416 papers receiving 15.7k citations

Hit Papers

The Cruciate Ligaments of the Knee Joint 1975 2026 1992 2009 1975 2007 2008 2003 2013 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Cruciate Ligaments of the Knee Joint
    1975 1.1k citations John L. Marshall et al. profile →
  2. Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study
    2007 665 citations John L. Marshall et al. Journal of Clinical Oncology profile →
  3. A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer
    2008 644 citations John L. Marshall et al. Journal of Clinical Oncology profile →
  4. Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial
    2003 510 citations John L. Marshall et al. Journal of Clinical Oncology profile →
  5. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
    2013 350 citations John L. Marshall et al. Journal of Clinical Oncology profile →
  6. Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients
    2018 333 citations Ari M. Vanderwalde, David Spetzler et al. Cancer Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John L. Marshall United States 66 7.6k 4.9k 3.6k 2.8k 1.9k 431 16.4k
Jan B. Vermorken Belgium 59 7.0k 0.9× 2.4k 0.5× 3.4k 0.9× 3.1k 1.1× 1.7k 0.9× 371 12.8k
Hans Gelderblom Netherlands 76 9.6k 1.3× 2.8k 0.6× 5.8k 1.6× 9.6k 3.5× 2.3k 1.2× 743 25.3k
Arnold Ganser Germany 78 4.6k 0.6× 3.2k 0.7× 9.6k 2.7× 1.4k 0.5× 2.5k 1.3× 752 27.1k
Francis J. Hornicek United States 71 4.6k 0.6× 5.3k 1.1× 4.6k 1.3× 9.2k 3.3× 2.4k 1.3× 453 19.4k
Hillard M. Lazarus United States 76 7.0k 0.9× 2.3k 0.5× 4.6k 1.3× 1.9k 0.7× 1.1k 0.6× 545 25.8k
Ayalew Tefferi United States 115 4.6k 0.6× 2.1k 0.4× 22.2k 6.2× 2.7k 1.0× 1.2k 0.6× 1.1k 54.7k
Pancras C.W. Hogendoorn Netherlands 85 6.9k 0.9× 4.0k 0.8× 5.1k 1.4× 15.7k 5.7× 3.3k 1.8× 443 26.7k
Alison Stopeck United States 43 8.6k 1.1× 966 0.2× 3.2k 0.9× 2.6k 0.9× 3.5k 1.9× 159 12.7k
Anthony T.�C. Chan Hong Kong 86 11.7k 1.5× 7.2k 1.5× 7.8k 2.2× 5.6k 2.0× 6.1k 3.2× 456 27.6k
Anthony F. Shields United States 59 4.5k 0.6× 1.5k 0.3× 2.2k 0.6× 2.9k 1.0× 2.0k 1.1× 360 11.9k

Countries citing papers authored by John L. Marshall

Since Specialization
Citations

This map shows the geographic impact of John L. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John L. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John L. Marshall more than expected).

Fields of papers citing papers by John L. Marshall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John L. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John L. Marshall. The network helps show where John L. Marshall may publish in the future.

Co-authorship network of co-authors of John L. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of John L. Marshall. A scholar is included among the top collaborators of John L. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John L. Marshall. John L. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weinberg, Benjamin A., Allison A. Fitzgerald, Zoe X. Malchiodi, et al.. (2024). Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC): Preliminary findings.. Journal of Clinical Oncology. 42(17_suppl). LBA4132–LBA4132. 2 indexed citations
2.
Millstein, Joshua, Joanne Xiu, Shivani Soni, et al.. (2024). Clinical and molecular characterization of AXL in colorectal cancer: CALGB (Alliance)/SWOG 80405 and real-world data.. Journal of Clinical Oncology. 42(16_suppl). 3145–3145. 1 indexed citations
3.
Espinoza, Magdalena, Andrew Elliott, Joanne Xiu, et al.. (2024). Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers. Nature Cancer. 5(7). 1121–1129. 11 indexed citations
4.
5.
Arai, Hiroyuki, Yasmine Baca, Francesca Battaglin, et al.. (2020). Molecular Characterization of Appendiceal Goblet Cell Carcinoid. Molecular Cancer Therapeutics. 19(12). 2634–2640. 18 indexed citations
6.
Abraham, Jim, Daniel Magee, Chiara Cremolini, et al.. (2020). Clinical Validation of a Machine-learning–derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer. Clinical Cancer Research. 27(4). 1174–1183. 35 indexed citations
7.
Pishvaian, Michael J., Hongkun Wang, Aiwu Ruth He, et al.. (2020). A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer. Clinical Cancer Research. 26(19). 5092–5101. 32 indexed citations
8.
Stein, Matthew K., Joanne Xiu, Michael G. Martin, et al.. (2020). Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma. Journal of Surgical Oncology. 121(8). 1320–1328. 18 indexed citations
9.
Tokunaga, Ryuma, Joanne Xiu, Curtis Johnston, et al.. (2019). Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer. Clinical Cancer Research. 25(10). 3096–3103. 62 indexed citations
10.
Tesfaye, Anteneh, Hongkun Wang, Marion L. Hartley, et al.. (2019). A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma. SHILAP Revista de lepidopterología. 5(1). 12–21. 4 indexed citations
11.
El‐Deiry, Wafik S., Richard M. Goldberg, Heinz‐Josef Lenz, et al.. (2019). The current state of molecular testing in the treatment of patients with solid tumors, 2019. CA A Cancer Journal for Clinicians. 69(4). 305–343. 187 indexed citations
12.
Vanderwalde, Ari M., David Spetzler, Nianqing Xiao, Zoran Gatalica, & John L. Marshall. (2018). Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients. Cancer Medicine. 7(3). 746–756. 333 indexed citations breakdown →
13.
Salem, Mohamed E., Alberto Puccini, Axel Grothey, et al.. (2018). Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers. Molecular Cancer Research. 16(5). 805–812. 159 indexed citations
14.
Hwang, Jimmy J., John Kuruvilla, David S. Mendelson, et al.. (2010). Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma. Clinical Cancer Research. 16(15). 4038–4045. 80 indexed citations
15.
Sutton, Gerard, et al.. (1995). Mannose 6-phosphate reduces haze following excimer laser photorefractive keratectomy. UCL Discovery (University College London). 5 indexed citations
16.
Lohmann, CP, et al.. (1994). A HISTOPATHOLOGICAL STUDY OF SURGICAL HUMAN SPECIMEN OF TISSUE RESPONSIBLE FOR HAZE AND REGRESSION AFTER EXCIMER-LASER PHOTOREFRACTIVE KERATECTOMY. UCL Discovery (University College London). 7 indexed citations
17.
Corbett, Melanie C., et al.. (1994). THE EFFECT OF COLLAGENASE INHIBITORS ON CORNEAL TRANSPARENCY AFTER EXCIMER-LASER PHOTOREFRACTIVE KERATECTOMY (PRK). UCL Discovery (University College London). 1 indexed citations
18.
Docchio, Franco, C. A. Sacchi, & John L. Marshall. (1986). Experimental Investigation of Optical Breakdown Thresholds in Ocular Media under Single Pulse Irradiation with Different Pulse Durations. UCL Discovery (University College London). 50 indexed citations
19.
Kendall, B. E. & John L. Marshall. (1974). Strokes—What Is Wanted of Radiology?. Journal of the Royal College of Physicians of London. 9(1). 30–40. 1 indexed citations
20.
Suter, Peter F., et al.. (1970). Clinical and Radiologic Survey of Canine Panosteitis. Journal of the American Veterinary Medical Association. 156(7). 870–883. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan B. Vermorken Breakdown of academic impact, for papers by Hans Gelderblom Breakdown of academic impact, for papers by Arnold Ganser Breakdown of academic impact, for papers by Francis J. Hornicek Breakdown of academic impact, for papers by Hillard M. Lazarus Breakdown of academic impact, for papers by Ayalew Tefferi Breakdown of academic impact, for papers by Pancras C.W. Hogendoorn Breakdown of academic impact, for papers by Alison Stopeck Breakdown of academic impact, for papers by Anthony T.�C. Chan Breakdown of academic impact, for papers by Anthony F. Shields
Rankless by CCL
2026